Insights from the 2022 R&D Innovation Survey
In this playbook, we share insights from 33 biopharma executives who reported their experience using these bellwether approaches for the 2022 R&D Innovation Survey conducted by Health Advances and Parexel Biotech. This innovation snapshot shows biotechs adopting new approaches and encountering a variety of roadblocks, but pushing forward to expand their use and deliver faster, more efficient development.
Considered as a whole, findings from the December 2022 R&D Innovation Survey lead us to three top-line insights:
- Regulatory and commercial strategies must be considered earlier.
- Adaptive designs, ECAs and DCTs are growing in importance.
- Biopharma must pursue new ways to increase diversity in clinical trials.
Related Insights
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Article
4 Insights on decentralized trials for biotechs
Jul 1, 2021
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Related Insights
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Article
4 Insights on decentralized trials for biotechs
Jul 1, 2021
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Podcast
De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
May 28, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Whitepaper
Overview of China's Market Approval Policy Med Insurance Payment System
Apr 7, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022